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1. Introduction
Concomitant with advances in civilisation, pharma-
ceutical drugs have become widely accessible and 
commonly used. Antibiotics, analgesic and hormo-
nal drugs are employed not only in human health 
care, but also in veterinary practice. As a result, in 
household and hospital sewage, agricultural sew-
age or in post-production waste of pharmaceutical 
industries, pharmaceutical products in unprocessed 
form as well as transformation products, the so-
called metabolites, may be found (Lahti & Oikari, 
2011; Zembrzuska et al., 2016). During sewage treat-
ment only a portion of pharmaceutical pollutants is 
permanently removed. At present, under binding 
legal regulations in Poland, it is not obligatory to 
monitor and reduce concentrations of pharmaceu-
ticals in post-production sewage or treated sewage 
that is released into the environment from sewage 
treatment plants. Similarly, there are no regulations 
for determining the permissible concentrations of 
pharmaceutical pollutants in drinking water.
In the literature, reports on measurable con-
centrations of drugs in surface and ground waters 
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(Kasprzyk-Hordern et al., 2008; Kuczyńska, 2017) 
and even in drinking water (Zwiener, 2007; Valcar-
cel et al., 2011; Caban et al., 2015) can be found. Al-
though the concentration of pharmaceuticals in wa-
ter is merely in the range of ng/dm3 in groundwater 
and μg/dm3 in surface water, the World Health 
Organisation has urged institutions worldwide to 
monitor the occurrence of pharmaceuticals in the 
aquatic environment, in view of their potential 
long-term impact on human health (WHO, 2012). 
At the same time, the European Commission has re-
leased a list of substances the circulation of which in 
the environment is to be monitored and the impact 
of which on the environment is to be evaluated (EU, 
2011, 2013). In the United States, an environmental 
evaluation is required if the drug’s concentration in 
water exceeds 1 μg/dm3 (Santos et al., 2010). The 
drugs which have not degraded entirely or have 
not been treated completely can be unknowingly 
consumed by humans. It should also be noted that 
in drinking water substances of various medication 
groups have been found. Such “medication mix-
tures” can trigger more strongly adverse drug reac-
tions, as a result of their reciprocal interaction, than 
in the case of a single substance. This may lead to 
serious health issues (Rizzo et al., 2015).
Therefore, it is of prime importance to recognise 
the migration of drugs in groundwater, including 
the processes that may delay their migration to-
wards groundwater intakes. We did research into 
recognising the migration of selected pharmaceu-
ticals in aquifers and identifying parameter values 
of their transport and sorption. The present paper 
discusses results of a test with diclofenac, a popular 
anti-inflammatory, analgesic and anti-pyretic drug 
belonging to the group of the non-steroidal anti-in-
flammatory drugs (NSAIDs) (ECHA, 2018). The ap-
plication of this pharmaceutical must be carefully 
overseen, because in the long run overdoses may 
lead to such health issues as liver impairment, kid-
ney deficiency or even impairment of organs that 
produce blood components (Dux et al., 1983; Knight 
et al., 2009). Diclofenac must not be taken by women 
in the third trimester of pregnancy, nor by patients 
with circulatory system problems and heart disease 
(Soubrier et al., 2013; Arfe et al., 2016). Moreover, 
diclofenac is toxic to aquatic organisms and poses 
a serious threat to the aquatic environment (Santos 
et al., 2010; Szymonik& Lach, 2012; Li, 2014; Acuna 
et al., 2015).
The rates of effectiveness of removing diclofenac 
from sewage by means of conventional methods 
and technology differ and range between 30 and 70 
per cent (Zając et al., 2015; Lonappan et al., 2016). 
The removal of diclofenac from sewage is more ef-
fective at those sewage treatment plants that apply 
biological treatment methods, i.e., that of activated 
sludge process, which uses micro-organisms. This 
reduces diclofenac by means of the process of bi-
odegradation rather than through adsorption on 
the surface of the sludge and its biodegradation is 
not complete (Larsson et al., 2013; Zając, 2017). Di-
clofenac is one of the NSAID drugs which is least 
susceptible to biological decomposition process-
es (Drozdek et al., 2018). However, Groning et al. 
(2007) reported on rapid microbiological degrada-
tion of diclofenac through biofilms of fluvial sed-
iment under oxic conditions. According to results 
published in the literature, a potentially effective 
method of removing diclofenac from water is the 
photodegradation process which occurs in ultravi-
olet radiation or in direct sunlight in the presence 
of semiconductors, typically metallic oxides (Czech, 
2012; Bohdziewicz et al., 2014; Kudlek et al., 2016). 
According to Serrano et al. (2001) diclofenac can be 
adsorbed in the membrane bioreactor with the ad-
dition of powder-activated carbon, which leads to 
a reduction in the drug’s concentration by 85 per 
cent. The adsorption of diclofenac on soil minerals 
is classified as low; the pharmaceutical fails to be 
adsorbed permanently and can be leached from 
soils (Lin & Gan, 2011, Caracciolo et al., 2015). Re-
searchers who conducted column tests aimed at 
recognising the transport behaviour and sorption 
processes of diclofenac include Mersmann et al. 
(2002), Scheytt et al. (2004) and Siemens et al. (2010). 
However, the number of studies on diclofenac sorp-
tion in various deposits appears to be still insuffi-
cient. In comparison to the limited number of mod-
els recorded in the literature, we considered a larger 
number of sorption models for the present paper.
2. Material and methods
2.1. Laboratory experiments
In the first stage of the experiments, we conducted 
a laboratory test in order to determine 1) whether 
diclofenac photodegrades in sunlight and 2) wheth-
er it can adsorb on the walls of the container used 
for keeping samples of the solution. Two sets of 
samples were prepared, signed with the letters “S” 
(sorption) and “SF” (sorption and photodegrada-
tion), as well as a zero sample. To prepare the solu-
tion, 5.10 mg of diclofenac was dissolved in 1 dm3 
of distilled water. After the solution was poured 
into containers, the zero sample was frozen and 
locked away from the light. The other samples were 
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put in a room with partially covered windows at a 
temperature of c. 20°C. Samples marked “S” were 
placed in a container that was cut off from direct 
sunlight, while samples marked “SF” were left un-
covered. Without the access of light, samples in 
each series were frozen after 1 h, 3 h, 6 h and 12 
hours following the start of the test. The final “S” 
sample was frozen after 24 hours; freezing halts the 
sorption process.
The diclofenac migration test through porous 
media was conducted in a plexi filtration column of 
9 cm in diameter and a length of 50 cm. In the test, 
the solution used was distilled water that contained 
chloride ions (Cl) and diclofenac (DIC). The column 
was filled with ball-shaped glass granules of 300–
400 µm in diameter (d10 = 0.28 mm) and a uniformity 
coefficient CU = 1.25. The other test looked into the 
migration of chloride ions and diclofenac in natu-
ral sediment, i.e., a sample of sandur sand obtained 
from a site north of the city of Poznań. This was a 
medium-grained quartz sand (d10 = 0.28 mm), with 
a total organic carbon (TOC) of 0.047 per cent and a 
trace amount of clay fraction. The sand sample con-
tained clay minerals such as smectite, illite and ka-
olinite. The sand uniformity coefficient CU was 1.83.
The flow through the filtration column was in-
duced by constant hydraulic gradient i. In the tests, 
flow rate Q was measured, which made it possible to 
determine the value of hydraulic conductivity k. The 
total porosity n was calculated by the weight meth-
od, based on measuring the weight of a dry sample 
of porous material m, its volume V and knowledge 
of the density of the matrix material ρs (Myślińska, 
1998). At first the effective porosity ne was calculat-
ed for connected pores by means of the volumetric 
method, measuring the volume of porous materi-
al V and the volume of water used to saturate the 
porous medium Vw. In the next step, the effective 
porosity ne was finally determined as the ratio of 
average filtration velocity va to effective velocity v 
calculated on the basis of average transport time 
of the chloride ions in the column (Kleczkowski, 
1984; Małecki et al., 2006). The solution injection 
took the form of a short-term pulse (Okońska, 2006). 
The tests were conducted in a darkened laboratory 
room. The samples of input and outflow solutions 
were placed in plastic containers, the chemical in-
difference of which was verified at the start of the 
laboratory work. Such plastic containers are more 
convenient for transporting samples and, unlike 
glass containers, they do not break during freezing 
and thawing processes (Wilga, 2008). Samples of the 
solution were kept frozen and away from light until 
they were analysed to determine the concentration 
of diclofenac and chloride ions.
Determination of diclofenac was performed 
with a chromatographic system UltiMate 3000 
RSLC (Dionex, Thermo, USA), coupled to an API 
4000 QTRAP triple quadrupole mass spectrometer 
with electrospray ionisation (ESI) (from AB Sciex, 
Foster City, CA, USA) in negative ionisation mode 
(UHPLC–ESI MS/MS). A Hypersil Gold C18 RP 
(100 mm × 2.1 mm, 1.9 μm particle size) column 
from Thermo Scientific, USA, was used for chroma-
tographic separation of compound. The tempera-
ture in the column of the chromatographic system 
was maintained at 35°C and the injection volume 
was 5.0 μL. For UHPLC–ESI MS/MS analysis the 
mobile phase was a gradient prepared from Milli-Q 
water containing 5 mmol/dm3 ammonium acetate 
(component A) and MeOH (component B). The fol-
lowing gradient was used: 0 min 30 per cent B, 10 
min 67 per cent B, 11 min 100 per cent B and held 
for 1 min; the flow rate was 0.2 mL/min. A post run 
time was set at 5.0 min for column equilibration be-
fore the next injection. The operating conditions for 
mass spectrometry for diclofenac were as follows: 
curtain gas 20 psi, nebuliser gas and auxiliary gas 
40 psi, source temperature 400°C, ion spray voltage 
−4,500 V and collision gas set to medium. Quanti-
tative analysis of the compounds was performed in 
multiple reaction monitoring (MRM) mode. For the 
analysis one transition of the deprotonated molecu-
lar ion and their respective ion product was chosen. 
These transitions (m/z) with associated decluster-
ing potentials (V) and collision energies (V) were: 
294 → 250, −40, −18; and 294 → 214, −40, −30.
Due to the presence of organic compounds in the 
water samples, the concentration of chloride ions 
was marked by means of the argentometric titration 
method. In the test, a burette of increased accuracy 
was used. However, due to the limited volume of 
the solution sample analysed, the measurement ac-
curacy was 2.5 mg Cl−/dm3.
2.2. Mathematical models
The mathematical description of the transport and 
sorption of substances in porous media considered 
by us (Okońska et al., 2017) refers to twelve differ-
ent models, all of which are symbolically represent-
ed in Table 1.
The transport of inert chloride ions was de-
scribed with a one-dimensional advection-disper-
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where C is the flux-averaged concentration of the 
substance in the liquid phase [M/L3](Kreft & Zuber, 
1978; Parker & van Genuchten, 1984), t is time [T], x 
is distance [L], v is effective water velocity [L/T], De 
is the effective diffusion coefficient [L2/T] and Dx is 
the longitudinal dispersivity coefficient [L2/T]. The 
velocity v was defined as kin
e
v = , where k is the hy-
draulic conductivity [L/T], i is the hydraulic gradi-
ent [L/L] and ne is the effective porosity [–]. The 
dispersivity coefficient Dx was defined as Dx = αv, 
where α is the longitudinal dispersivity [L]. Accord-
ing to the calculated Peclet number, the influence of 
molecular diffusion on the substance’s migration 
through the porous media can be neglected. There-
fore, the coefficient De equal to 0 m2/s in the mathe-
matical model was assumed.






















where ρd is the bulk density of the porous medium 
[M/L3] and the variable s, describing equilibrium 
sorption se and non-equilibrium sorption sn, can be 
substituted with an equation s = se + sn.
The relative recovery of chloride ions and di-
clofenac was calculated with the Descriptors2.m 
code (Okońska & Pietrewicz, 2018; Okońska et al., 
2019). Next, on the basis of the mathematical model 
selection algorithm (Fig. 1), out of the eleven sorp-
tion models under examination, the following three 
models, which can be used to describe diclofenac 
sorption in the porous medium, were selected:
1. The irreversible kinetic sorption model (I model)




= k C1  (3)
where k1 is the irreversible sorption rate coefficient 
[L3/MT];
2. The Henry model with the irreversible kinetic 
sorption model (H–I model)




= k C1  (4)
where KH is the Henry distribution coefficient 
[L3/M];
3. The Freundlich model with the irreversible ki-
netic sorption model (F–I model)
Table 1. An overview of mathematical models under con-
sideration
Advection-dispersion model Sorption model
A–D
H F L
I H–I F–I L–I
R H–R F–R L–R
H – Henry model, F – Freundlich model, L – Langmuir 
model, I – irreversible sorption model, R – reversible 
sorption model, H–I – Henry with irreversible sorp-
tion model, F–I – Freundlich with irreversible sorp-
tion model, L–I – Langmuir with irreversible sorption 
model, H–R – Henry with reversible sorption mod-
el, F–R – Freundlich with reversible sorption model, 
L–R – Langmuir with reversible sorption model.
Fig. 1. Algorithm of mathematical model identification 
and parameter estimation
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= k C1  (5)
where KF is the Freundlich sorption coefficient 
[L3/M], and nF is the Freundlich sorption exponent 
[–].
The results of the column test itself do not make 
it clear whether the observed mass reduction of di-
clofenac during its migration through the column 
is an effect of irreversible sorption or of the degra-
dation process. On the basis of preliminary data, 
we ruled out the possible impact of photodegrada-
tion on the mass balance of diclofenac. At the same 
time, due to the short duration of the column test, 
development of micro-organisms was not possible, 
which in turn ruled out biodegradation. Photocatal-
ysis was not possible, and no additional chemical 
reagents were introduced to the column, except for 
the substances examined, which causes that chemi-
cal degradation may not be considered. Thus, it can 
be stated explicitly that the dominant process was 
irreversible sorption.
In order to solve partial differential equations 
to describe the migration of substances through the 
column, column test standard boundary conditions 
were assumed. For the flow and solution injection 
at column input, Dirichlet boundary condition was 
assumed, while at column output Neumann bound-
ary condition was applied (Okońska et al., 2017).
2.3. Numerical analysis
Identification of parameters of transport and sorp-
tion and numerical solution of the adopted mathe-
matical model were conducted in a MATLAB en-
vironment (Okońska et al., 2017). In order to solve 
the model of transport, which is composed of the 
partial differential equation with appropriate initial 
and boundary conditions for pulse-type injection, 
pdepe function (implemented in MATLAB) was 
used. The function combines the finite element (for 
discretization in space) and the finite difference (for 
time discretization) methods assuming triangular 
meshing. In order to avoid numerical dispersion, 
the time intervals between laboratory data were 
supplemented numerically by additional points 
using interpolation. The numerical solutions were 
tested using an analytical benchmark. The identi-
fication of transport and sorption parameters was 
performed with the help of the built-in lsqcurvefit 
function dedicated to the solution of non-linear op-
timisation problems assuming least-square fitting.
To that end, a calculation code Id_Test_Kol4.m 
with the functional interface Id_Test_Kol4.fig were 
used, which required, in an A-D model, to enter the 
data from the column test and the initial values of 
longitudinal dispersivity α. At the same time, when 
determining the value of this parameter, the value 
of hydraulic conductivity k was further detailed 
due to the possible measurement error of ±10 per 
cent. In the sorption models, apart from the data ob-
tained from the column test, initial values of sorp-
tion parameters were entered, which were estimat-
ed over subsequent iterative steps.
Evaluation of the quality of fit of theoretical and 
experimental breakthrough curves of the migra-
tion of chloride ions and diclofenac was done by 
applying curve parameters: root mean square error 
(RMSE) and correlation coefficient r (Małecki et al., 
2006).
The next stage involved calculation of the value 
of retardation R on the basis of the value obtained 
through optimisation of the Henry distribution co-
efficient KH or the Freundlich sorption coefficient 
KF, respectively (Okońska, 2006; Kret et al., 2015):













3. Results and discussion
3.1. Laboratory test
Based on the outcome of the laboratory test, it can 
be assumed that under the conditions applied, di-
clofenac is not photodegradable in sunlight and 
does not adsorb on the walls of the plastic container 
intended for keeping the solution samples (Fig. 2).
Fig. 2. Concentrations of diclofenac in water samples: S – 
sorption, SF – sorption and photodegradation
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Cases described in the literature show that the 
process of photodegradation by exposure to sunlight 
or UV radiation is more intense when catalytic agents 
and organic substances in soil samples are present. In 
the porous media under examination, characterised 
by a lack of or by an inconsiderable content of organ-
ic substances, plus limited access of direct sunlight, 
the scale of decay of the pharmaceutical through the 
process of photodegradation can be neglected.
3.2. Experimental breakthrough curves
Values of flow parameters and injection data re-
corded during the column tests are presented in Ta-
ble 2. These data confirm similar conditions of flow 
and injection in both cases analysed.
The analysis of the normalised breakthrough 
curves of chloride ions and diclofenac through po-
rous media (Fig. 3) revealed a similar transport be-
haviour of the substance on both glass granules and 
sand. Practically, retardation of diclofenac migration 
compared to chloride ions is not observed, while the 
mass balance of the pharmaceutical at column input 
and output indicates a reduction in the drug’s mass 
during its migration through both types of porous 
media. The calculated recovery of diclofenac is 95 
per cent for glass granules and 89 per cent for sand.
3.3. Migration parameters
Calculated (with the help of identified parameters) 
numerical breakthrough curves of chloride ions 
and diclofenac through glass granules and sand are 
shown in Figure 4, while the identified values of 
advection-dispersion and sorption parameters are 
presented in Table 3.
A good fit of theoretical and experimental break-
through curves was obtained. As far as the A–D 
models are concerned, the RMSE was in the range 
of 0.1–0.2 mg/dm3, and coefficient r in the range 
0.993–0.999.
The value of hydraulic conductivity k, obtained 
through the optimisation in a MATLAB environ-
ment, of the chloride ions breakthrough curve, is 
lower than the value measured during the experi-
ment, i.e., by 2.4 per cent for glass granules and by 
0.7 per cent for sand, which is comfortably within 
the measurement error.
The determined values of longitudinal disper-
sivity α are 0.0015 m for glass granules and 0.0013 
for sand. The values measured in both types of po-
rous media are similar and characteristic of tests on 
a laboratory scale. They indicate the homogeneity 
of the porous media under examination. The results 
obtained are consistent with the assumptions and 
correspond with uniformity coefficient CU.
Table 2. Flow and injection parameters registered during column tests
Parameter Symbol Unit Glass granules Sand
Sample length x m 0.470 0.458
Hydraulic gradient i – 0.043 0.044
Total porosity n – 0.39 0.36
Effective porosity ne – 0.36 0.34
Volumetric flow rate Q cm3/s 0.158 0.152
Hydraulic conductivity k m/s 5.85 × 10−4 5.47 × 10−4
Cl/DIC concentration in the injected solution C0 mg/dm3 300/2.388 300/2.398
Injection time tin min 46 44
Fig. 3. Experimental breakthrough curves
 Laboratory investigations of diclofenac migration in saturated porous media – a case study 219
The migration of diclofenac in the porous media 
is best described by the F–I model when it comes 
to glass granules, and by the H–I model where 
sand is concerned. Moreover, the above-mentioned 
sorption models obtained the highest indicator val-
ues with regard to the fit of theoretical and experi-
mental breakthrough curves of the pharmaceutical 
in question (RMSE = 0.016 mg/dm3, r = 0.988 and 
RMSE = 0.021 mg/dm3, r = 0.987, respectively). In 
the optimisation process, sand obtained the nF = 1 
Freundlich exponent in the F–I model, the equation 
assumed the character of a linear isotherm.
Table 3. Parameters of transport and sorption calculated in MATLAB
Parameter Symbol Unit Glass granules Sand
A–D model
Hydraulic conductivity k m/s 5.71 × 10−4 5.43 × 10−4
Dispersivity α m 0.0015 0.0013
Root mean square error RMSE mg/dm3 0.200 0.103
Correlation coefficient r – 0.993 0.999
I model
Irreversible sorption rate coefficient k1 dm3/kg s 7.09 × 10−6 6.22 × 10−6
Root mean square error RMSE mg/dm3 0.044 0.025
Correlation coefficient r – 0.907 0.980
H–I model
Henry distribution coefficient KH dm3/kg 1.42 × 10−2 4.15 × 10−3
Irreversible sorption rate coefficient k1 dm3/kg s 3.70 × 10−6 6.07 × 10−6
Root mean square error RMSE mg/dm3 0.024 0.021
Correlation coefficient r – 0.973 0.987
F–I model
Freundlicha sorption coefficient KF dm3/kg 6.35 × 10−3 4.15 × 10−3
Freundlich sorption exponent nF – 2 1
Irreversible sorption rate coefficient k1 dm3/kg s 2.86 × 10−6 6.07 × 10−6
Root mean square error RMSE mg/dm3 0.016 0.021
Correlation coefficient r – 0.988 0.987
Fig. 4. Theoretical breakthrough curves calculated in MATLAB against experimental points
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The value of retardation R, calculated on the ba-
sis of the Freundlich sorption parameters according 
of equation (7) for glass granules, is 1.11, with the 
diclofenac concentration C equal to 2.116 mg/dm3, 
and the bulk density of the porous medium ρd 1.51 
g/cm3. The value of retardation R, calculated on the 
basis of the Henry distribution coefficient accord-
ing to equation (6) for sand, is 1.02, with the bulk 
density of the porous medium ρd 1.70 g/cm3. The 
obtained values of R signify a slight retardation of 
the migration of the former medium and no retar-
dation of the latter. The findings obtained prove 
that diclofenac is transported through the samples 
at roughly the same velocity as chloride ions, but 
during the process the mass of the pharmaceutical 
is reduced by 5 to 11 per cent, depending on the me-
dia type. We proved that the loss in mass is an ef-
fect of irreversible sorption on porous material. The 
findings of the experiments rule out the possibility 
of drug degradation through exposure to light or 
its adsorption on the walls of containers used for 
water samples.
The findings of the tests correspond with litera-
ture data, and also with observations on the migra-
tion of pharmaceuticals published by Bertelkamp et 
al. (2014), who found that the retardation for most 
of the compounds analysed was close to 1. Scheytt 
et al. (2004), in their column tests with medium sand 
of TOC = 2.4 g/kg (0.24%), and a pharmaceutical 
concentration of 10 μg/dm3 in injected groundwa-
ter, found that retardation of diclofenac was R = 2.0, 
with a recovery figure of 97 per cent. The R was cal-
culated as the ratio of velocity of water and that of 
the pharmaceutical.
The migration of diclofenac as a single com-
pound could be slightly less intensive as proved 
by Mersmann et al. (2002), who carried out a test 
involving only this particular drug, i.e., without 
addition of any other pharmaceuticals. The retar-
dation obtained by those authors was R = 2.6, with 
the diclofenac concentration being 10 μg/dm3 in 
injected water.
The literature offers a way of approximate cal-
culation of the distribution coefficient KH on the ba-
sis of predicted distribution coefficient KOC and the 
content of total organic carbon, TOC% (Małecki et 
al., 2006). The value of coefficient KOC for diclofenac 
can be found in the works of Mersmann et al. (2002) 
and Scheytt et al. (2004). The distribution coeffi-
cient KH for diclofenac migration in sand, calculat-
ed by means of the above-mentioned method, was 
3.76–5.92 × 10−2 dm3/kg and turned out to be an or-
der of magnitude higher than the parameter value 
obtained in the column test with the sand sample 
analysed.
4. Conclusions
The present note discusses findings of a test on the 
migration of diclofenac through filtration columns 
filled with two types of porous media: glass granules 
and sandur sand, with a low content of organic car-
bon. The test was conducted under oxic conditions, 
with concentrations of the drug slightly higher than 
observed in the environment. As the preliminary 
laboratory test findings revealed that under condi-
tions of the experiment the photodegradation pro-
cess did not occur, diclofenac sorption was examined 
on grains. The conditions in the darkened laboratory 
room, where the column tests were conducted, to a 
certain degree reflected those of the saturation zone, 
where the photodegradation process cannot take 
place due to a lack of sunlight and UV radiation. The 
limited access of light and short duration of the test 
ensured that micro-organisms had no time and not 
enough light to grow and develop. During the exper-
iment photocatalysis was not possible, and no addi-
tional chemical reagents were introduced to the col-
umn, with the exception of the substances examined. 
This rules out biological or chemical degradation in 
the processes under consideration. The test findings 
revealed that in saturated porous media diclofenac 
migrates as rapidly as chloride ions. Retardation was 
close to 1, which indicates diclofenac mobility. In the 
case of migration, taking into account the sorption 
in accordance with the Freundlich model, it is possi-
ble that the value of retardation R will be higher de-
pending on the concentration of the pharmaceutical 
in groundwater (Eq. 7).
The findings also showed a small irreversible 
sorption of diclofenac on glass granules and sand 
grains, resulting in a mass loss of the drug of 5 to 
11 per cent. This means that, taken the low content 
of organic substances and the absence of micro-or-
ganisms in aquifers, water will not be self-purified 
by means of degradation of the drug. Therefore, the 
ground water protection system should be aimed 
at reducing the possibility of diclofenac reaching 
groundwater, particularly in aquifers that are locat-
ed near groundwater intake points.
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